Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay

Journal of Virology

Volumn 79, Issue 9, 2005, Pages 5684-5694

  Kaufhold, Robin M ^a   Field, Jodie A ^a   Caulfield, Michael J ^a   Wang, Su ^a   Joseph, Heather ^a   Wooters, Melissa A ^a   Green, Tina ^a   Clark, H Fred ^b   Krah, David ^a   Smith, Jeffrey G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; PROTEIN VP6; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN VP4; VIRUS PROTEIN VP7;

ANTIBODY TITER; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; GASTROENTERITIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAVIRUS; T LYMPHOCYTE; ULTRAVIOLET RADIATION; VACCINATION; VIRUS INACTIVATION; VIRUS STRAIN;

ADULT; AGED; ANTIGENS, VIRAL; CELLS, CULTURED; HUMANS; IMMUNITY, CELLULAR; IMMUNOENZYME TECHNIQUES; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; ROTAVIRUS; ROTAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES;

BOVINAE; HUMAN ROTAVIRUS A; ROTAVIRUS;

EID: 20244374264     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.9.5684-5694.2005     Document Type: Article

References (41)

1. Altfeld, M., M. M. Addo, R. Shankarappa, P. K. Lee, T. M. Allen, X. G. Yu, A. Rathod, J. Harlow, K. O'Sullivan, M. N. Johnston, P. J. R. Goulder, J. I. Mullins, E. S. Rosenberg, C. Brander, B. Korber, and B. D. Walker. 2003. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J. Virol. 77:7330-7340.
2. Azim, T., M. H. Zaki, G. Podder, N. Sultana, M. A. Salam, S. M. Rahman, Sefat-e-Khuda, and D. A. Sack. 2003. Rotavirus-specific subclass antibody and cytokine responses in Bangladeshi children with rotavirus diarrhoea. J. Med. Virol. 69:286-295.
3. Bass, D. M. 1997. Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113:81-89.
4. Brown, K. A., J. A. Kriss, C. A. Moser, W. J. Wenner, and P. A. Offit. 2000. Circulating rotavirus-specific antibody-secreting cells (ASCs) predict the presence of rotavirus-specific ASCs in the human small intestinal lamina propria. J. Infect. Dis. 182:1039-1043.
5. Chiba, S., S. Nakata, S. Ukae, and N. Adachi. 1993. Virological and serological aspects of immune resistance to rotavirus gastroenteritis. Clin. Infect. Dis. 16(Suppl. 12):S117-S121.
6. Chiba, S., T. Yokoyama, S. Nakata, Y. Morita, T. Urasawa, K. Taniguchi, S. Urasawa, and T. Nakao. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet ii:417-421.
7. Clark, H. F., P. A. Offit, R. W. Ellis, J. J. Eiden, D. Krah, A. R. Shaw, M. Pichichero, J. J. Treanor, F. E. Borian, L. M. Bell, and S. A. Plotkin. 1996. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J. Infect. Dis. 174(Suppl. 1):S73-S80.
8. Clark, H. F., P. A. Offit, R. W. Ellis, D. Krah, A. R. Shaw, J. J. Eiden, M. Pichichero, and J. J. Treanor. 1996. WC3 reassortant vaccines in children. Arch. Virol. Suppl. 12:187-198.
9. Clemens, J. D., R. L. Ward, M. R. Rao, D. A. Sack, D. R. Knowlton, F. P. L. vanLoon, S. Huda, M. McNeal, F. Ahmed, and G. Schiff. 1992. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J. Infect. Dis. 165:161-165.
10. Cunliffe, N. A., B. K. Das, M. Ramachandran, M. K. Bhan, R. I. Glass, and J. R. Gentsch. 1997. Sequence analysis demonstrates that VP6, NSP1 and NSP4 genes of Indian neonatal rotavirus strain 116E are of human origin. Virus Genes 15:39-44.
11. + T lymphocytes. J. Virol. 64:4375-4382.
12. Hjelt, K., P. C. Grauballe, A. Paerregaard, O. H. Nielsen, and P. A. Krasilnikoff. 1987. Protective effect of preexisiting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J. Med. Virol. 21:39-47.
13. + T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults. J. Virol. 76:4741-4749.
14. Jiang, B., J. R. Gentsch, and R. I. Glass. 2002. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin. Infect. Dis. 34:1351-1361.
15. Kapikian, A. Z., Y. Hoshino, and R. M. Chanock. 2001. Rotaviruses, p. 1787-1833. In D. M. Knipe, P. M. Howley, and D. E. Griffin (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams and Wilkins, Philadelphia, Pa.
16. + T-cell-mediated clearance of rotavirus in SCID mice. J. Virol. 75:5482-5490.
17. Levin, M. J., J. G. Smith, R. M. Kaufhold, D. Barber, A. R. Hayward, C. Y. Chan, I. S. F. Chan, D. J. J. Li, W. Wang, P. M. Keller, A. Shaw, J. L. Silber, K. Schlienger, I. Chalikonda, S. J. R. Vessey, and M. J. Caulfield. 2003. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine J. Infect. Dis. 188:1336-1344.
18. McNeal, M. M., J. L. VanCott, A. H. C. Choi, M. Basu, J. A. Flint, S. C. Stone, J. D. Clements, and R. L. Ward. 2002. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J. Virol. 76:560-568.
19. Merchant, A. A., W. S. Groene, E. H. Cheng, and R. D. Shaw. 1991. Murine intestinal antibody response to heterologous rotavirus infection. J. Clin. Microbiol. 29:1693-1701.
20. Midthun, K., and A. Z. Kupikian. 1996. Rotavirus vaccines: an overview. Clin. Microbiol. Rev. 9:423-434.
21. Molyneaux, P. J. 1995. Human immunity to rotavirus. J. Med. Microbiol. 43:397-404.
22. Morrison, D. F. 1990. Multivariate statistical methods, 3rd ed. McGraw-Hill, New York, N.Y.
23. Mwau, M., A. J. McMichael, and T. Hanke. 2002. Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. AIDS Res. Hum. Retrovir. 18:611-618.
24. Offit, P. A., and H. F. Clark. 1998. The rotavirus vaccine. Curr. Opin. Pediatr. 11:9-13.
25. Offit, P. A., and K. I. Dudzik. 1989. Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J. Virol. 63:3507-3512.
26. Offit, P. A., and K. I. Dudzik. 1990. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J. Virol. 64:6325-6328.
27. Offit, P. A., E. J. Hoffenberg, E. S. Pia, P. A. Panackal, and N. L. Hill. 1992. Rotavirus-specific helper T cell responses in newborns, infants, children, and adults. J. Infect. Dis. 165:1107-1111.
28. Offit, P. A., E. J. Hoffenberg, N. Santos, and V. Gouvea. 1993. Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J. Infect. Dis. 167:1436-1440.
29. O'Ryan, M. L., D. O. Matson, M. K. Estes, and L. K. Pickering. 1994. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J. Infect. Dis. 169:504-511.
30. Rojas, A. M., Y. Boher, M. J. Guntiñas, and I. Pérez-Schael. 1995. Homotypic immune response to primary infection with rotavirus serotype G1. J. Med. Virol. 47:404-409.
31. + T cells. Virology 314:671-679.
32. Smith, J. G., X. Liu, R. M. Kaufhold, J. Clair, and M. J. Caulfield. 2001. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin. Diagn. Lab. Immunol. 8:871-879.
33. Tang, B., J. M. Gilbert, S. M. Matsui, and H. B. Greenberg. 1997. Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis. Virology 237:89-96.
34. Tucker, A. W., A. C. Haddix, J. S. Bresee, R. C. Holman, U. D. Parashar, and R. I. Glass. 1998. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 279:1371-1376.
35. VanCott, J. L., M. M. McNeal, J. Flint, S. A. Bailey, A. H. C. Choi, and R. L. Ward. 2001. Role for T cell-independent B cell activity in the resolution of primary rotavirus infection in mice. Eur. J. Immunol. 31:3380-3387.
36. Velázquez, F. R., D. O. Matson, M. L. Guerrero, J. Shults, J. J. Calva, A. L. Morrow, R. I. Glass, L. K. Pickering, and G. M. Ruiz-Palacios. 2000. Serum antibody as a marker of protection against natural rotavirus infection and disease. J. Infect. Dis. 182:1602-1609.
37. + type 1 responses in humans by a malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 98:10817-10822.
38. Ward, R. L. 2003. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol. 16:17-24.
39. Ward, R. L., and D. I. Bernstein. 1995. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. Vaccine 13:1226-1232.
40. Ward, R. L., J. D. Clemens, D. R. Knowlton, M. R. Rao, F. P. L. vanLoon, N. Huda, F. Ahmed, G. M. Schiff, and D. A. Sack. 1992. Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J. Infect. Dis. 166:1251-1257.
41. Yasukawa, M., O. Nakagomi, and Y. Kosayashi. 1990. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans. Clin. Exp. Immunol. 80:49-55.